Table 3.

The outcome from Nasal NK/T-cell lymphoma in the Mexican population.

	Radiotherapy	Chemotherapy		Combined Therapy
Stages	I–II	I–II	III–IV	I–II	III–IV
Complete response	73%	45%	NT+	90%	60%
Progression-free survival *	48%	40%	NT	84%	60%
Overall survival *	71%	37%	NT	91%	65%%

⁺Not treated,

^*Actuarial curves to 10 years.